期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

脑利钠肽前体在老年慢性阻塞性肺病患者的意义

下载PDF
导出
摘要 目的探讨老年慢性阻塞性肺病(COPD)患者血浆脑利钠肽前体(pro-BNP)水平的临床意义。方法测定69例老年COPD患者血浆pro-BNP水平,并与动脉血氧分压(PaO2)及左心室射血分数(LVEF)进行相关分析。结果老年COPD患者pro-BNP水平与LVEF水平及PaO2水平均呈负相关。结论pro-BNP测定有助于老年COPD患者心功能不全的诊断,可以作为指导抗心力衰竭治疗的指标。
作者 丁弘 包纪盛
机构地区 南京医科大学附属无锡二院心内科 南京医科大学附属无锡二院老年科
出处 《江西医药》 CAS 2007年第5期429-430,共2页 Jiangxi Medical Journal
关键词 脑利钠肽前体 老年 慢性阻塞性肺病
分类号 R563.3 [医药卫生—呼吸系统]
  • 相关文献

参考文献4

  • 1Maisel S,Koon J,Krishnaswamy P,et al.Utility of BNP as a rapid,point of care test for screening patients undergoing echocardiography to determine left vent ricular dysfunction.Am Heart J,2001,14:367.
  • 2Shapiro BP,Chen HH,Burnett JCJ,et al.Use of plasma brain natriureticpeptide concentration to aid in the diagnosis of heart failure.Mayo Clin Proc,2003,78:4812486.
  • 3孙同文,张彦周.脑钠肽与心功能不全[J].新医学,2005,36(2):119-122. 被引量：10
  • 4Ishii J,Nomura M,Ito M,et al.Plasma concentration of brainnatriuretic peptide as a biochemical marker for the evaluation of right ventricular overload and mortality in chronic respiratorydisease.Clin Chim Acta,2000,301:19.

二级参考文献23

  • 1Maisel AS, Koon J, Krishnaswamy P, et aL Utility of B-type natriuretic peptide as a rapid, paint-of-case test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J, 2001,141 (3) : 367-374.
  • 2Lubien E, DeMeria A, Krishnaswamy P, et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction : comparison with Dopplor velocity recordings. Circulation, 2002, 105 (5): 595-601.
  • 3Ishii J, Nomura M, ho M, et al. Plasma concentration of brain natriuretic peptide as a biochemical marker for the evaluation of right ventricular overload and mortality in chronic respiratory disease. Clin Chim Atca,2000, 301 (1-2): 19-30.
  • 4Mariano-Goulart D, Eberle MC, Boudousq V, et al. Major increase in brain natriuretic peptide indicates right ventricular systolic dysfunction in patients with heart failure. EurJ Heart Fail, 2003, 5 (4): 481..488.
  • 5Yu CM, Sanderson JE. Plasma brain natriuretic peptide-an independent predictor of cardiovascular mortality in acute heart failure. Eur J Heart Fail. 1999, 1 (1): 59-65.
  • 6Tsutamoto T, Wada A, Maeda K, et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure:prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation, 1997,96 (2): 509-516.
  • 7Anand IS, Fisher LD, Chiang YT, et aL Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial(Val-HeFT). Circulation, 2003, 107 (9) :1278-1283.
  • 8Ishii J, Nomum M, Nakamura Y, et al. Risk stratification using a com-bination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure. Am J Cardiol, 2002, 89(6): 691-695.
  • 9Mordoeh DR, McDonagh TA, Byrne J, et aL Titration of vasodiLator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the hemodynamic and neuroendocrine effects of hailored versus empirical therapy. Am Heart J, 1999,138(6 Pt1):1126-1132.
  • 10Andreassi MG, Silvia DR, Palmieri C, et aL Up-regulation of'dear-ance' receptors in patients with chronic heart failure: a possible explanation for the resistance to biological effects of cardiac natriuretic hormone Eur J Heart Fail, 2001, 3 (4) : 407-414.

共引文献9

江西医药
2007年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部